Skip to main content
Premium Trial:

Request an Annual Quote

PEOPLE: Silicon Genetics Hires New Marketing VP; GCI s Dougherty Leaves for Drug Developer

This update serves to clarify a misstatement of fact. Michael Pellini, CEO of Genomics Collaborative, will not become COO of the company following Michael Dougherty's departure. Instead, he will assume the title of president and CEO. GenomeWeb regrets the error.


NEW YORK, Nov. 13-Silicon Genetics appointed Kevin Wandryk as vice president of marketing and business development, the company said today.


He was previously in marketing at the internet B-to-B software companies Quova and AdKnowledge, and had spent 10 years at Adobe Systems.


Silicon Genetics, based in Redwood City, Calif., is  a bioinformatics company that builds gene expression anlysis software.



Genomics Collaborative president and chief operating officer Michael Dougherty has joined Adolor as senior vice president of commercial operations, the company said on Nov. 7.


Dougherty joined GCI in January 2001. Prior to that, he spent seven years at Magainin Pharmaceuticals, now called Genaera Corporation, where he was eventually promoted to CEO.


GCI chief executive officer Michael Pellini, who originally joined the company in July 1999, will now also take on the role of president.


Adolor is a drug-development company focusing on treatments for pain.



Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at [email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics, that appears every Wednesday.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.